PLEURO-PULMONARY MANIFESTATIONS IN CONNECTIVE TISSUE DISORDERS IN SUDANESE PATIENTS: CROSS-SECTIONAL STUDY

Authors

  • Omer Elgaili Yousif ELHAG Al-Neelain university
  • Khalid Hassan KHALID Omdurman Islamic university
  • AllaEldin Hassan AHAMED University of Khartoum
  • El EDRISSY Mawahib National Ribat universit
  • Ahamed SADELDIN Alzaeim Alazhari university
  • Ali Mohammed ALI Shendi university
  • Awadelkareem Massad AWADELKAREEM Shendi university

DOI:

https://doi.org/10.52692/1857-0011.2024.3-80.13

Keywords:

Connective Tissue Disorders , Interstitial Lung Disease , Pulmonary Arterial Hypertension , Pulmonary Function Tests, High-Resolution Computed Tomography , Sudan

Abstract

Background: Connective Tissue Disorders (CTDs) frequently affect the respiratory system, with complications such as interstitial lung disease (ILD), pulmonary arterial hypertension (PAH), and pleural effusions being major contributors to morbidity and mortality. This study investigates the prevalence and patterns of pulmonary manifestations in Sudanese patients with CTDs and evaluates diagnostic correlations using pulmonary function tests (PFTs) and high-resolution computed tomography (HRCT). Material and Methods. A cross-sectional study was conducted involving 75 CTDs patients presenting with respiratory symptoms at hospitals in Khartoum, Sudan. Data collection included clinical evaluations, PFTs, HRCT scans, and laboratory investigations. Statistical analyses were performed to determine the prevalence of pulmonary complications and their correlations with CTDs subtypes. Results. ILD was the most common manifestation, with an overall prevalence of 36%, particularly high in scleroderma (75%) and MCTD (60%). Pulmonary arterial hypertension (PAH) was observed in 4%, primarily in systemic lupus erythematosus (9.5%). PFT abnormalities were common, with restrictive defects dominating in MCTD (100%) and scleroderma (87.5%). HRCT findings included reticulonodular lesions (14.7%), honeycombing (12%), pleural effusions (8%), and bronchiectasis (4%). Statistically significant differences in pulmonary complications were observed across CTDs subtypes. Conclusion. Pulmonary manifestations are prevalent in Sudanese CTDs patients, with ILD being the predominant complication. Early and systematic screening using PFTs and HRCT is crucial for timely detection and management. These findings highlight the need for enhanced multidisciplinary care and further research into regional variations in CTD-related pulmonary diseases.

Author Biographies

Omer Elgaili Yousif ELHAG , Al-Neelain university

MD, PhD, Associate Professor

Khalid Hassan KHALID, Omdurman Islamic university

Assistant Professor

AllaEldin Hassan AHAMED, University of Khartoum

Dr. habilitat of medicine, Professo

El EDRISSY Mawahib, National Ribat universit

Medic, doctor în științe, conferențiar universitar

Ahamed SADELDIN, Alzaeim Alazhari university

Medic, doctor în științe, conferențiar universitar

Ali Mohammed ALI , Shendi university

Associate Professor

Awadelkareem Massad AWADELKAREEM, Shendi university

Assistant Professor

References

Agarwal R, Gaur SN, Bhagat R, Jindal SK. Pulmonary involvement in connective tissue disorders: A study from north India. Indian J Chest Dis Allied Sci. 2012;54(1):57-63.

Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972–2002. Ann Rheum Dis. 2007;66(7):940-4.

Goh NS, Desai SR, Veeraraghavan S, et al. Interstitial lung disease in systemic sclerosis: A simple staging system. Am J Respir Crit Care Med. 2008;177(11):1248-54.

Simonneau G, Montani D, Celermajer DS, et al. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2019;53(1):1801913.

Hassoun PM. Pulmonary arterial hypertension in systemic sclerosis. Rheum Dis Clin North Am. 2015;41(3):403-22.

Wells AU. Pulmonary function tests in connective tissue disease. Semin Respir Crit Care Med. 2007;28(4):379-88.

Fischer A, du Bois R. Interstitial lung disease in connective tissue disorders. Lancet. 2012;380(9842):689-98.

Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med. 2002;165(12):1581-6.

Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733-48.

Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement: Interstitial pneumonia with autoimmune features. Eur Respir J. 2015;46(4):976-87.

George PM, Spagnolo P, Kreuter M, et al. Progressive fibrosing interstitial lung disease: Clinical uncertainties, consensus recommendations, and research priorities. Lancet Respir Med. 2020;8(9):925-34.

Downloads

Published

2025-09-09

Issue

Section

Research Article

Categories